ArticleBlood2018

Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma.

Han W Tun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.